---
figid: PMC11103046__gr1
figtitle: Cardioprotective Mechanisms of SGLT2 Inhibitors Against Cancer Treatment–Induced
  CardiotoxicitySodium-glucose cotransporter-2 (SGLT2) inhibitors protect against
  cardiovascular toxicity induced by anticancer drugs via multiple mechanisms
organisms:
- NA
organisms_ner:
- Homo sapiens
pmcid: PMC11103046
filename: PMC11103046__gr1.jpg
figlink: /pmc/articles/PMC11103046/figure/F1
number: F1
caption: Cardioprotective Mechanisms of SGLT2 Inhibitors Against Cancer Treatment–Induced
  CardiotoxicitySodium-glucose cotransporter-2 (SGLT2) inhibitors protect against
  cardiovascular toxicity induced by anticancer drugs via multiple mechanisms. They
  enhance energy metabolism by increasing the activation of nutrient deprivation pathways
  (adenosine monophosphate-activated protein kinase [AMPK] and sirtuin [SIRT] 1, SIRT3,
  and SIRT6) while inhibiting the nutrient surplus pathways (AKT/mammalian target
  of rapamycin [mTOR]), resulting in enhanced autophagy and increased mitochondrial
  biogenesis (peroxisome proliferator–activated receptor-γ coactivator-1α [PGC-1α]).
  Additionally, SGLT2 inhibitors mitigate oxidative and endoplasmic reticulum (ER)
  stress, block inflammatory pathways, inhibit ferroptosis, and enhance ketogenesis.
  Created using BioRender.com. ATF-4 = activating transcription factor 4; CHOP = C/EBP
  homologous protein; eIF-2α = eukaryotic initiation factor 2α; Ho-1 = heme oxygenase
  1; MDA = malondialdehyde; MMP = matrix metalloproteinase; NLRP-3 = nod-like receptor
  pyrin domain containing 3; NF-κB = nuclear factor κB; NOX-1 = NADPH oxidase 1; NOX-2 = NADPH
  oxidase 2; Nrf-2 = nuclear factor erythroid 2–related factor 2; NQO1 = NAD(P)H quinone
  dehydrogenase 1; PERK = protein kinase R-like endoplasmic reticulum kinase; ROS = reactive
  oxygen species; SOD = superoxide dismutase; TNF = tumor necrosis factor
papertitle: The Cardioprotective and Anticancer Effects of SGLT2 Inhibitors
reftext: Mohamed S. Dabour, et al. JACC CardioOncol. 2024 Apr;6(2).
year: '2024'
doi: 10.1016/j.jaccao.2024.01.007
journal_title: 'JACC: CardioOncology'
journal_nlm_ta: JACC CardioOncol
publisher_name: Elsevier
keywords: anthracyclines | cancer | cardio-oncology | cardiotoxicity | SGLT2 inhibitors
automl_pathway: 0.5846384
figid_alias: PMC11103046__F1
figtype: Figure
redirect_from: /figures/PMC11103046__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC11103046__gr1.html
  '@type': Dataset
  description: Cardioprotective Mechanisms of SGLT2 Inhibitors Against Cancer Treatment–Induced
    CardiotoxicitySodium-glucose cotransporter-2 (SGLT2) inhibitors protect against
    cardiovascular toxicity induced by anticancer drugs via multiple mechanisms. They
    enhance energy metabolism by increasing the activation of nutrient deprivation
    pathways (adenosine monophosphate-activated protein kinase [AMPK] and sirtuin
    [SIRT] 1, SIRT3, and SIRT6) while inhibiting the nutrient surplus pathways (AKT/mammalian
    target of rapamycin [mTOR]), resulting in enhanced autophagy and increased mitochondrial
    biogenesis (peroxisome proliferator–activated receptor-γ coactivator-1α [PGC-1α]).
    Additionally, SGLT2 inhibitors mitigate oxidative and endoplasmic reticulum (ER)
    stress, block inflammatory pathways, inhibit ferroptosis, and enhance ketogenesis.
    Created using BioRender.com. ATF-4 = activating transcription factor 4; CHOP = C/EBP
    homologous protein; eIF-2α = eukaryotic initiation factor 2α; Ho-1 = heme oxygenase
    1; MDA = malondialdehyde; MMP = matrix metalloproteinase; NLRP-3 = nod-like receptor
    pyrin domain containing 3; NF-κB = nuclear factor κB; NOX-1 = NADPH oxidase 1;
    NOX-2 = NADPH oxidase 2; Nrf-2 = nuclear factor erythroid 2–related factor 2;
    NQO1 = NAD(P)H quinone dehydrogenase 1; PERK = protein kinase R-like endoplasmic
    reticulum kinase; ROS = reactive oxygen species; SOD = superoxide dismutase; TNF = tumor
    necrosis factor
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - DDIT3
  - EIF2S1
  - EIF2A
  - EIF2AK3
  - ATF4
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - PPARGC1A
  - FUT3
  - NFE2L2
  - HMOX1
  - NOX1
  - NQO1
  - CYBB
  - SOD1
  - SOD2
  - SOD3
  - NLRP3
  - TNF
  - NFKB1
  - MMP9
---
